SERPING1 and hereditary angioedema: One systematic review on randomized controlled trials concluded with C1-INH replacement therapy as an effective treatment for LTP in the management of HAE, with ≥ 90% reductions in HAE attack frequency achieved which could represent freedom from disease activity in clinical practice [57].